(secondQuint)A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD).

 This is a randomized, double-blind, placebo controlled, multi-center outpatient study, in adults with GAD.

 Patients 18-65 years of age, with the diagnosis of GAD according to DSM-IV criteria, who fulfill the inclusion/exclusion criteria, will be enrolled in this study.

 This is a randomized, double-blind, placebo controlled, multi-center outpatient study, in adults with GAD.

 Patients 18-65 years of age, with the diagnosis of GAD according to DSM-IV criteria, who fulfill the inclusion/exclusion criteria, will be enrolled in this study.

.

 A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)@highlight

This is a randomized, double-blind, placebo controlled, multi-center outpatient study, in adults with GAD.

 Patients 18-65 years of age, with the diagnosis of GAD according to DSM-IV criteria, who fulfill the inclusion/exclusion criteria, will be enrolled in this study.

